September 13, 2023
- Registrational Phase III trial in Type 1 Diabetes with Diamyd® expands to the US
- Sharing the Access Code to Help Open Up Diabetes Care
- Tubeless insulin pump receives FDA clearance for people with diabetes
- Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars’ Business In North America, Ahead of Schedule
